 Connection
Eric Lavonas to Agkistrodon
This is a "connection" page, showing publications Eric Lavonas has written about Agkistrodon.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
6.863 |
|
|
|
-
Lavonas EJ, Burnham RI, Schwarz J, Quackenbush E, Lewis B, Rose SR, Greene S, Toschlog EA, Charlton NP, Mullins ME, Schwartz R, Denning D, Sharma K, Kleinschmidt K, Bush SP, Anderson VE, Ginde AA, Gerardo CJ. Recovery from Copperhead Snake Envenomation: Role of Age, Sex, Bite Location, Severity, and Treatment. J Med Toxicol. 2020 01; 16(1):17-23.
Score: 0.692
-
Lavonas EJ, Anderson VE, Gerardo CJ. In reply to Dr. Shah and Dr. Beuhler. Clin Toxicol (Phila). 2020 03; 58(3):223-224.
Score: 0.686
-
Gerardo CJ, Vissoci JRN, Evans CS, Simel DL, Lavonas EJ. Does This Patient Have a Severe Snake Envenomation?: The Rational Clinical Examination Systematic Review. JAMA Surg. 2019 04 01; 154(4):346-354.
Score: 0.672
-
Lavonas EJ, Anderson VE, Gerardo CJ. Response to carpenter and colleagues. Clin Toxicol (Phila). 2019 07; 57(7):674-676.
Score: 0.666
-
Mullins ME, Gerardo CJ, Bush SP, Rose SR, Greene S, Quackenbush EB, Lewis B, Anderson VE, Kleinschmidt KC, Schwarz RB, Charlton NP, Toschlog EA, Sharma K, Denning DA, Lavonas EJ. Adverse Events in the Efficacy of Crotalidae Polyvalent Immune Fab Antivenom vs Placebo in Recovery from Copperhead Snakebite Trial. South Med J. 2018 12; 111(12):716-720.
Score: 0.657
-
Lavonas EJ, Gerardo CJ. Letter to the editor: "Safety of nonsteroidal anti-inflammatory drugs in copperhead snakebite patients" by Pham and Mullins, Clin Toxicol 2018 May 18. Clin Toxicol (Phila). 2019 02; 57(2):144-145.
Score: 0.651
-
Anderson VE, Gerardo CJ, Rapp-Olsson M, Bush SP, Mullins ME, Greene S, Toschlog EA, Quackenbush E, Rose SR, Schwartz RB, Charlton NP, Lewis B, Kleinschmidt KC, Sharma K, Lavonas EJ. Early administration of Fab antivenom resulted in faster limb recovery in copperhead snake envenomation patients. Clin Toxicol (Phila). 2019 01; 57(1):25-30.
Score: 0.646
-
Gerardo CJ, Quackenbush E, Lewis B, Rose SR, Greene S, Toschlog EA, Charlton NP, Mullins ME, Schwartz R, Denning D, Sharma K, Kleinschmidt K, Bush SP, Ryan S, Gasior M, Anderson VE, Lavonas EJ. The Efficacy of Crotalidae Polyvalent Immune Fab (Ovine) Antivenom Versus Placebo Plus Optional Rescue?Therapy on Recovery From Copperhead Snake Envenomation: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial. Ann Emerg Med. 2017 Aug; 70(2):233-244.e3.
Score: 0.593
-
Lavonas EJ, Gerardo CJ. Prospective study of recovery from copperhead snake envenomation: an observational study. BMC Emerg Med. 2015 May 15; 15:9.
Score: 0.514
-
Gerardo CJ, Evans CS, Kuchibhatla M, Mando-Vandrick J, Drake WG, Yen M, Kopec K, Lavonas EJ. Time to antivenom administration is not associated with total antivenom dose administered in a copperhead-predominant snakebite population. Acad Emerg Med. 2015 Mar; 22(3):308-14.
Score: 0.506
-
Lavonas EJ, Gerardo CJ, O'Malley G, Arnold TC, Bush SP, Banner W, Steffens M, Kerns WP. Initial experience with Crotalidae polyvalent immune Fab (ovine) antivenom in the treatment of copperhead snakebite. Ann Emerg Med. 2004 Feb; 43(2):200-6.
Score: 0.235
-
Freiermuth CE, Lavonas EJ, Anderson VE, Kleinschmidt KC, Sharma K, Rapp-Olsson M, Gerardo C. Antivenom Treatment Is Associated with Fewer Patients using Opioids after Copperhead Envenomation. West J Emerg Med. 2019 May; 20(3):497-505.
Score: 0.169
-
Gerardo CJ, Lavonas EJ, McKinney RE. Ethical considerations in design of a study to evaluate a US Food and Drug Administration-approved indication: antivenom versus placebo for copperhead envenomation. Clin Trials. 2014 Oct; 11(5):560-4.
Score: 0.121
-
Thorson A, Lavonas EJ, Rouse AM, Kerns WP. Copperhead envenomations in the Carolinas. J Toxicol Clin Toxicol. 2003; 41(1):29-35.
Score: 0.054
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|